Aberrant RNA splicing events in acute lymphoblastic leukemia underlies resistance to immunotherapy
Aberrant splicing of messenger RNAs encoding surface antigen CD22 leads to downregulation of this protein in pediatric B-lymphoblastic leukemia (B-ALL), rendering malignant cells resistant to the effects of CD22-directed ...
Jan 4, 2022
0
28